COMMUNIQUÉS West-GlobeNewswire

-
Arch Biopartners Granted Pre-Ind Meeting With FDA for Candidate Drug to Prevent Acute Kidney Injury
21/03/2018 -
Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative
21/03/2018 -
Chiesi to Become Presenting Sponsor of North Carolina Football Club’s Spread Your Wings Foundation
21/03/2018 -
Checkpoint Therapeutics Initiates Dose Expansion Portion of Phase 1 Trial of Anti-PD-L1 Antibody CK-301
21/03/2018 -
Cidara Therapeutics Provides Clinical Data Updates for its Lead Antifungal Rezafungin
21/03/2018 -
Meridian Bioscience Realigns Organizational Structure
21/03/2018 -
Helix BioPharma Corp. Signs Collaboration Agreement With ProMab Biotechnologies to Co-Develop CAR-T for Hematological Malignancies
21/03/2018 -
Geron to Present at the Needham Healthcare Conference
21/03/2018 -
KemPharm, Inc. to Report Fourth Quarter and Year End 2017 Results
21/03/2018 -
SuperSonic Imagine’s Aixplorer® Ultimate Highlighted at American Institute of Ultrasound in Medicine Meeting in New York
21/03/2018 -
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results
21/03/2018 -
Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference
21/03/2018 -
Bringing Generations Together Through Music
21/03/2018 -
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec To Manufacture Universal Donor Cell Therapies
21/03/2018 -
Nabriva Therapeutics Appoints Jennifer Schranz, M.D., as Chief Medical Officer
21/03/2018 -
Capricor Therapeutics to Present at Upcoming Oppenheimer and Needham Healthcare Conferences
21/03/2018 -
Recro Pharma to Present at the 17th Annual Needham Healthcare Conference
21/03/2018 -
Akari Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Clinical Progress
21/03/2018 -
Fennec Pharmaceuticals Receives Fast Track Designation by FDA for PEDMARK
21/03/2018
Pages